Investigational Drug Information for Volixibat
✉ Email this page to a colleague
What is the drug development status for Volixibat?
Volixibat is an investigational drug.
There have been 5 clinical trials for Volixibat.
The most recent clinical trial was a Phase 1 trial, which was initiated on January 4th 2021.
The most common disease conditions in clinical trials are Cholangitis, Cholestasis, and Cholangitis, Sclerosing. The leading clinical trial sponsors are Mirum Pharmaceuticals, Inc., Shire, and [disabled in preview].
There are six US patents protecting this investigational drug and one hundred and fifty-four international patents.
Summary for Volixibat
US Patents | 6 |
International Patents | 154 |
US Patent Applications | 33 |
WIPO Patent Applications | 8 |
Japanese Patent Applications | 0 |
Clinical Trial Progress | Phase 1 (2021-01-04) |
Vendors | 16 |
Recent Clinical Trials for Volixibat
Title | Sponsor | Phase |
---|---|---|
A Study to Evaluate Efficacy and Safety of an Investigational Drug Named Volixibat in Patients With Itching Caused by Primary Biliary Cholangitis | Mirum Pharmaceuticals, Inc. | Phase 2 |
A Placebo-controlled Study of Volixibat in Subjects With Elevated Serum Bile Acids Associated With Intrahepatic Cholestasis of Pregnancy (OHANA) | Mirum Pharmaceuticals, Inc. | Phase 2 |
A Study to Evaluate Efficacy and Safety of an Investigational Drug Named Volixibat in Patients With Itching Caused by Primary Sclerosing Cholangitis (PSC) | Mirum Pharmaceuticals, Inc. | Phase 2 |
Clinical Trial Summary for Volixibat
Top disease conditions for Volixibat
Top clinical trial sponsors for Volixibat
US Patents for Volixibat
Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
---|---|---|---|---|
Volixibat | ⤷ Try a Trial | Bile acid recycling inhibitors and satiogens for treatment of diabetes, obesity, and inflammatory gastrointestinal conditions | SATIOGEN PHARMACEUTICALS, INC. (San Diego, CA) | ⤷ Try a Trial |
Volixibat | ⤷ Try a Trial | Bile acid recycling inhibitors and satiogens for treatment of diabetes, obesity, and inflammatory gastrointestinal conditions | SATIOGEN PHARMACEUTICALS, INC. (San Diego, CA) | ⤷ Try a Trial |
Volixibat | ⤷ Try a Trial | Bile acid recycling inhibitors for treatment of pediatric cholestatic liver diseases | LUMENA PHARMACEUTIALS LLC (Lexington, MA) | ⤷ Try a Trial |
Volixibat | ⤷ Try a Trial | Methods for treating cholestasis | MIRUM PHARMACEUTICALS, INC. (Foster City, CA) | ⤷ Try a Trial |
>Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Volixibat
Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
---|---|---|---|---|
Volixibat | European Patent Office | EP2575821 | 2030-05-26 | ⤷ Try a Trial |
Volixibat | European Patent Office | EP2995317 | 2030-05-26 | ⤷ Try a Trial |
Volixibat | European Patent Office | EP3593802 | 2030-05-26 | ⤷ Try a Trial |
Volixibat | Spain | ES2552657 | 2030-05-26 | ⤷ Try a Trial |
>Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |